造血幹細胞移植(HSCT)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8103004)・商品コード:GIR8103004
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月4日
・ページ数:136
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥365,400見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥548,100見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥730,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、造血幹細胞移植(HSCT)の世界市場について調べ、まとめました。種類別セグメントは、自家移植、同種異系移植等、用途別セグメントは、白血病、リンパ増殖性疾患、固形腫瘍、非悪性疾患、その他等に区分しました。造血幹細胞移植(HSCT)の世界市場概観、メーカー動向、メーカー別造血幹細胞移植(HSCT)シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・造血幹細胞移植(HSCT)の市場概観
・造血幹細胞移植(HSCT)のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・造血幹細胞移植(HSCT)のメーカー別販売動向、市場シェア、市場集中度、競争動向
・造血幹細胞移植(HSCT)の世界市場規模
・造血幹細胞移植(HSCT)の北米市場分析(アメリカ、カナダ、メキシコ等)
・造血幹細胞移植(HSCT)のアメリカ市場規模推移
・造血幹細胞移植(HSCT)のカナダ市場規模推移
・造血幹細胞移植(HSCT)のメキシコ市場規模推移
・造血幹細胞移植(HSCT)のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・造血幹細胞移植(HSCT)のドイツ市場規模推移
・造血幹細胞移植(HSCT)のイギリス市場規模推移
・造血幹細胞移植(HSCT)のロシア市場規模推移
・造血幹細胞移植(HSCT)のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・造血幹細胞移植(HSCT)の日本市場規模推移
・造血幹細胞移植(HSCT)の中国市場規模推移
・造血幹細胞移植(HSCT)の韓国市場規模推移
・造血幹細胞移植(HSCT)のインド市場規模推移
・造血幹細胞移植(HSCT)の東南アジア市場規模推移
・造血幹細胞移植(HSCT)の南米市場分析(ブラジル、アルゼンチン等)
・造血幹細胞移植(HSCT)の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・造血幹細胞移植(HSCT)の種類別分析/市場規模推移(自家移植、同種異系移植)
・造血幹細胞移植(HSCT)の用途別分析/市場規模推移(白血病、リンパ増殖性疾患、固形腫瘍、非悪性疾患、その他)
・造血幹細胞移植(HSCT)の市場予測(地域別予測、種類別予測、用途別予測)
・造血幹細胞移植(HSCT)の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Hematopoietic stem cell transplants (HSCT) present to a valid treatment for several congenital and other hematopoietic system disorders, post chemotherapy, and immune sensitive diseases. HSCT is also preferred for replacement of cellular components and deficient cells. The indications for HSCT thus are wide; the most frequent indication as per reported by Worldwide Network for Blood and Marrow Transplantation Group (WNBT) (2013) is lymphoproliferative disorder (53.2% of all HSCT), 12% of whom received allogeneic and the rest received autologous transplant. Plasma cell disorders are the most frequent indication in this group. A multitude of literature published by researchers and organizations demonstrate that autologous transplant own a greater edge against allogeneic HSCT.

Scope of the Report:

This report studies the Hematopoietic Stem Cells Transplantation (HSCT) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hematopoietic Stem Cells Transplantation (HSCT) market by product type and applications/end industries.

Over 30 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.

Hematopoietic stem cells are unable to proliferate and differentiate in-vitro. Researchers have yet to evolve an accurate method to differentiate stem cells from other cells derived from blood or bone marrow. Once such technical barriers are overcome, the avenues for realizing the full potential of HSCT. The type of transplant a person receives depends on several different factors, including the type and course of the disease, availability of suitable donors, and the patient’s overall health. There are three different sources of hematopoietic stem cells such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The stem cell source used for a given transplant depends upon the underlying disease, the type of transplant (allogeneic or autologous), and size of the patient.

The global Hematopoietic Stem Cells Transplantation (HSCT) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hematopoietic Stem Cells Transplantation (HSCT).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Kite Pharma

Thermo Fisher Scientific

CellGenix Technologie Transfer

Cesca Therapeutics

R&D Systems

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Autologous Transplant

Allogenic Transplant

Market Segment by Applications, can be divided into

Leukemia

Lymphoproliferative Disorders

Solid Tumors

Non-Malignant Disorders

Others

【レポートの目次】

Table of Contents

1 Hematopoietic Stem Cells Transplantation (HSCT) Market Overview

1.1 Product Overview and Scope of Hematopoietic Stem Cells Transplantation (HSCT)

1.2 Classification of Hematopoietic Stem Cells Transplantation (HSCT) by Types

1.2.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Comparison by Types (2017-2023)

1.2.2 Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Types in 2017

1.2.3 Autologous Transplant

1.2.4 Allogenic Transplant

1.3 Global Hematopoietic Stem Cells Transplantation (HSCT) Market by Application

1.3.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Leukemia

1.3.3 Lymphoproliferative Disorders

1.3.4 Solid Tumors

1.3.5 Non-Malignant Disorders

1.3.6 Others

1.4 Global Hematopoietic Stem Cells Transplantation (HSCT) Market by Regions

1.4.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Hematopoietic Stem Cells Transplantation (HSCT) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Hematopoietic Stem Cells Transplantation (HSCT) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hematopoietic Stem Cells Transplantation (HSCT) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Hematopoietic Stem Cells Transplantation (HSCT) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hematopoietic Stem Cells Transplantation (HSCT) Status and Prospect (2013-2023)

1.5 Global Market Size of Hematopoietic Stem Cells Transplantation (HSCT) (2013-2023)

2 Manufacturers Profiles

2.1 Kite Pharma

2.1.1 Business Overview

2.1.2 Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Kite Pharma Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Thermo Fisher Scientific

2.2.1 Business Overview

2.2.2 Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

2.3 CellGenix Technologie Transfer

2.3.1 Business Overview

2.3.2 Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Cesca Therapeutics

2.4.1 Business Overview

2.4.2 Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Cesca Therapeutics Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

2.5 R&D Systems

2.5.1 Business Overview

2.5.2 Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 R&D Systems Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Competition, by Players

3.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Hematopoietic Stem Cells Transplantation (HSCT) Players Market Share

3.2.2 Top 10 Hematopoietic Stem Cells Transplantation (HSCT) Players Market Share

3.3 Market Competition Trend

4 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Regions

4.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Market Share by Regions

4.2 North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

4.3 Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

4.5 South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

5 North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries

5.1 North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries (2013-2018)

5.2 USA Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

5.3 Canada Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

5.4 Mexico Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

6 Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries

6.1 Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries (2013-2018)

6.2 Germany Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

6.3 UK Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

6.4 France Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

6.5 Russia Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

6.6 Italy Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries

7.1 Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries (2013-2018)

7.2 China Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

7.3 Japan Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

7.4 Korea Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

7.5 India Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

8 South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries

8.1 South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries (2013-2018)

8.2 Brazil Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

8.3 Argentina Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

8.4 Colombia Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Hematopoietic Stem Cells Transplantation (HSCT) by Countries

9.1 Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

9.3 UAE Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

9.4 Egypt Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

9.6 South Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

10 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Segment by Type

10.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Market Share by Type (2013-2018)

10.2 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Forecast by Type (2018-2023)

10.3 Autologous Transplant Revenue Growth Rate (2013-2023)

10.4 Allogenic Transplant Revenue Growth Rate (2013-2023)

11 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Segment by Application

11.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Application (2013-2018)

11.2 Hematopoietic Stem Cells Transplantation (HSCT) Market Forecast by Application (2018-2023)

11.3 Leukemia Revenue Growth (2013-2018)

11.4 Lymphoproliferative Disorders Revenue Growth (2013-2018)

11.5 Solid Tumors Revenue Growth (2013-2018)

11.6 Non-Malignant Disorders Revenue Growth (2013-2018)

11.7 Others Revenue Growth (2013-2018)

12 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size Forecast (2018-2023)

12.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size Forecast (2018-2023)

12.2 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Forecast by Regions (2018-2023)

12.3 North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

12.4 Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

12.6 South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Hematopoietic Stem Cells Transplantation (HSCT) Picture

Table Product Specifications of Hematopoietic Stem Cells Transplantation (HSCT)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) and Revenue (Million USD) Market Split by Product Type

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Types in 2017

Figure Autologous Transplant Picture

Figure Allogenic Transplant Picture

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) by Application (2013-2023)

Figure Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Applications in 2017

Figure Leukemia Picture

Figure Lymphoproliferative Disorders Picture

Figure Solid Tumors Picture

Figure Non-Malignant Disorders Picture

Figure Others Picture

Table Global Market Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) and Growth Rate (2013-2023)

Table Kite Pharma Basic Information, Manufacturing Base and Competitors

Table Kite Pharma Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

Table Kite Pharma Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors

Table Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

Table Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

Table CellGenix Technologie Transfer Basic Information, Manufacturing Base and Competitors

Table CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

Table CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

Table Cesca Therapeutics Basic Information, Manufacturing Base and Competitors

Table Cesca Therapeutics Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

Table Cesca Therapeutics Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

Table R&D Systems Basic Information, Manufacturing Base and Competitors

Table R&D Systems Hematopoietic Stem Cells Transplantation (HSCT) Type and Applications

Table R&D Systems Hematopoietic Stem Cells Transplantation (HSCT) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) by Players (2013-2018)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Players (2013-2018)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Players in 2016

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Players in 2017

Figure Global Top 5 Players Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share in 2017

Figure Global Top 10 Players Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share in 2017

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) by Regions (2013-2018)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Regions (2013-2018)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Regions (2013-2018)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Regions in 2017

Figure North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Table North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries (2013-2018)

Table North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries (2013-2018)

Figure North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries (2013-2018)

Figure North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries in 2017

Figure USA Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Canada Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Mexico Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Table Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries (2013-2018)

Figure Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries in 2017

Figure Germany Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure UK Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure France Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Russia Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Italy Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries in 2017

Figure China Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Japan Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Korea Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure India Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Table South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Countries (2013-2018)

Table South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries (2013-2018)

Figure South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries (2013-2018)

Figure South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries in 2017

Figure Brazil Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Argentina Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Colombia Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure UAE Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Egypt Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure Nigeria Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Figure South Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue and Growth Rate (2013-2018)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) by Type (2013-2018)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Type (2013-2018)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Type (2013-2018)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Type in 2017

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Forecast by Type (2018-2023)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Market Share Forecast by Type (2018-2023)

Figure Global Autologous Transplant Revenue Growth Rate (2013-2018)

Figure Global Allogenic Transplant Revenue Growth Rate (2013-2018)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Application (2013-2018)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Application (2013-2018)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Application (2013-2018)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Share by Application in 2017

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Forecast by Application (2018-2023)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Market Share Forecast by Application (2018-2023)

Figure Global Leukemia Revenue Growth Rate (2013-2018)

Figure Global Lymphoproliferative Disorders Revenue Growth Rate (2013-2018)

Figure Global Solid Tumors Revenue Growth Rate (2013-2018)

Figure Global Non-Malignant Disorders Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

Figure Europe Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

Figure South America Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Forecast (2018-2023)



【レポートのキーワード】

造血幹細胞移植(HSCT)、自家移植、同種異系移植、白血病、リンパ増殖性疾患、固形腫瘍、非悪性疾患、その他

★調査レポート[造血幹細胞移植(HSCT)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8103004)販売に関する免責事項を必ずご確認ください。
★調査レポート[造血幹細胞移植(HSCT)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆